Testing statins for Crohn's disease before and after surgery
Treatments studied
Part of Digestive system clinical trials.
This study tests whether taking a statin (a cholesterol-lowering medicine) before and after surgery for Crohn's disease can help improve outcomes. It's for people with a specific type of Crohn's that causes narrowing in the small intestine and who are already scheduled for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stricturing Crohn's disease (a type that causes narrowing of the intestine).
- You are scheduled for surgery to remove the narrowed part of the end of your small intestine (terminal ileum) at Stanford University or a specified practice in Los Angeles.
- You are not pregnant, nursing, or planning to become pregnant in the next 6-12 months.
- You do not have severe kidney disease (stage 5 or end-stage).
- You are not allergic or have not had a bad reaction to statins before.
- You are not currently taking a statin medication or certain other drugs (like antifungals, fibrates, some antibiotics, etc.) without your doctor's okay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares medical treatment with surgery for people with Crohn's disease who have a narrowing (stricture) in their small intestine that causes blockages. The goal is to see which approach is better at managing symptoms and preventing complications.
This study compares two ways to choose biologic (targeted) medicines after Crohn’s surgery to help stop Crohn’s from coming back in the bowel. It may help you avoid or delay repeat inflammation by adjusting treatment based on endoscopy findings.
This study tests whether a special surgical technique (mesentery-embedding) is safe for people with Crohn's disease who need ileocolic surgery and are already on a biologic medication. It aims to see if this method can help reduce complications.
This early study looks at how a statin (cholesterol-lowering medicine) affects people with primary sclerosing cholangitis (PSC) by measuring changes using multiple types of health data. It may help researchers understand which people benefit and how PSC biology changes with treatment.
This trial tests whether adding a common cholesterol-lowering drug (a statin) to standard chemotherapy before surgery can improve outcomes for people with esophageal or gastroesophageal junction cancer. The goal is to see if the statin helps shrink the tumor and reduces the chance of the cancer coming back.
This trial tests whether taking a cholesterol-lowering medicine (a statin) after certain aortic surgeries can reduce harmful changes in the heart and other organs. You might benefit by lowering the risk of ongoing damage after your acute aortic condition and surgery.
Hear when a new Crohn's Ileocolitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.